skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: CRISPR-Based Antibacterials: Transforming Bacterial Defense into Offense

Abstract

Here, the development of antimicrobial-resistant (AMR) bacteria poses a serious worldwide health concern. CRISPR-based antibacterials are a novel and adaptable method for building an arsenal of antibacterials potentially capable of targeting any pathogenic bacteria.

Authors:
 [1]
  1. Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)
Publication Date:
Research Org.:
Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)
Sponsoring Org.:
USDOE National Nuclear Security Administration (NNSA)
OSTI Identifier:
1444085
Report Number(s):
SAND-2018-4534J
Journal ID: ISSN 0167-7799; 663937
Grant/Contract Number:  
AC04-94AL85000
Resource Type:
Accepted Manuscript
Journal Name:
Trends in Biotechnology
Additional Journal Information:
Journal Volume: 36; Journal Issue: 2; Journal ID: ISSN 0167-7799
Publisher:
Elsevier
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; CRISPR; antibacterial; genome editing; antibiotic resistance; bacteriophage; nanoparticle

Citation Formats

Greene, Adrienne Celeste. CRISPR-Based Antibacterials: Transforming Bacterial Defense into Offense. United States: N. p., 2017. Web. doi:10.1016/j.tibtech.2017.10.021.
Greene, Adrienne Celeste. CRISPR-Based Antibacterials: Transforming Bacterial Defense into Offense. United States. doi:10.1016/j.tibtech.2017.10.021.
Greene, Adrienne Celeste. Fri . "CRISPR-Based Antibacterials: Transforming Bacterial Defense into Offense". United States. doi:10.1016/j.tibtech.2017.10.021. https://www.osti.gov/servlets/purl/1444085.
@article{osti_1444085,
title = {CRISPR-Based Antibacterials: Transforming Bacterial Defense into Offense},
author = {Greene, Adrienne Celeste},
abstractNote = {Here, the development of antimicrobial-resistant (AMR) bacteria poses a serious worldwide health concern. CRISPR-based antibacterials are a novel and adaptable method for building an arsenal of antibacterials potentially capable of targeting any pathogenic bacteria.},
doi = {10.1016/j.tibtech.2017.10.021},
journal = {Trends in Biotechnology},
number = 2,
volume = 36,
place = {United States},
year = {2017},
month = {11}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Save / Share:

Works referencing / citing this record:

Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges
journal, March 2019

  • Cattoir, Vincent; Felden, Brice
  • The Journal of Infectious Diseases, Vol. 220, Issue 3
  • DOI: 10.1093/infdis/jiz134